Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 177 results found. Search for [ Covaxin production ]

Results 1 to 21 of 177
PTI
June 13, 2021
The hospitals have sought a proper mechanism and a single-window system to be put in place for procurement of vaccine doses


BusinessToday.In
June 9, 2021
A 64-member team of the paramilitary force will protect the registered office and plant of the pharma company located at Genome Valley in the Shameerpet area of Hyderabad


PTI
June 6, 2021
The remarks by the Russian president came a day after officials in New Delhi said the Serum Institute of India has received preliminary approval from the country's drug regulator for manufacturing of Sputnik V


BusinessToday.In
June 3, 2021
The Union Health Ministry will make an advance payment of Rs 1,500 crore to Hyderabad-based drugmaker Biological-E for what will be the second made-in-India vaccine following Bharat Biotech's Covaxin


PTI
June 1, 2021
Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India


PTI
May 30, 2021
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.


PTI
May 30, 2021
In a letter to all states and UTs, Additional Secretary to Health ministry Manohar Agnani said it has come to the notice of the ministry that some private hospitals are giving package for COVID vaccination in collaboration with some hotels


BusinessToday.In
May 29, 2021
The Delhi government has floated the global tender to scale up the COVID-19 vaccination drive in the national capital


PTI
May 29, 2021
IIL's Managing Director K Anand Kumar said the firm is expected to produce the drug substance initially for 2-3 million doses per month


PTI
May 29, 2021
Hyderabad-based Bharat Biotech said the timeline for manufacturing, testing and release for a batch of Covaxin is around 120 days, depending on the technology framework and regulatory guidelines to be met


PB Jayakumar
May 28, 2021
While official data shows 2.1 crore doses of Covaxin had been administered across the country till Thursday, based on statements from Bharat Biotech and Centre, at least 6 crore doses should have been produced and available for vaccination


Akshaya Nath
May 28, 2021
If functional, the IVC has the capacity to produce one billion vaccines annually. This means it can cater to a large part of the demand of Tamil Nadu as well as the rest of the country


BusinessToday.In
May 28, 2021
The MoU stated that Hester will provide complete infrastructure to manufacture the indigenously developed anti-COVID vaccine


Dr Srivatsa Krishna
New Delhi, May 26, 2021
While there are many critics of the government's vaccine strategy, over 75% of 18+ Indians could be vaccinated by October '21


BusinessToday.In
May 25, 2021
WHO's EUL authorisation is a pre-requisite for COVAX facility, which is meant to ensure COVID-19 vaccine supply to poorer nations. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines


BusinessToday.In
May 24, 2021
The company is aiming to submit the emergency use application by June. \"We still think we should be able to submit (the vaccine for emergency use authorisation) in May,\" MD Sharvil Patel said


BusinessToday.In
May 24, 2021
A guidance document on WHO website, updated last week, showed that Bharat Biotech submitted expression of interest for EUL on April 19.


Reuters
May 22, 2021
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects


BusinessToday.In
May 21, 2021
Responding to a question on whether Bharat Biotech would be open to make the production of Covaxin open to other entities, Ella said this might not be the best way forward


Reuters
May 21, 2021
Doing so, IMF officials say, would inject the equivalent of $9 trillion into the global economy by 2025 due to a faster resumption of economic activity, with rich countries potentially benefiting the most


PAGES 1 OF 9  12345